Abstract
Multicentric Castleman disease is a rare benign lymphoproliferative disorder associated with excessive interleukin-6 production. It typically presents with systemic features and can involve multiple organs, including the lymph nodes, lungs, skin, and kidneys. Because some cases of multicentric Castleman disease show high serum IgG4 level and numerous IgG4-positive plasma cell (IgG4+PCs) infiltrates within lymph nodes and other tissues, this disease of sometimes difficult to differentiate it from IgG4-related disease (IgG4-RD) on the basis of histological findings alone.
Relatively little attention has been given to the kidneys with regard to differentiating between these two diseases. We therefore report here our own experience with three cases of multicentric Castleman disease that presented with tubulointerstitial nephritis mimicking IgG4-related kidney disease. The relative paucity of fibrosis and the absence of immune complex deposition in the Castleman cases helped distinguish this diagnosis from IgG4-related kidney disease. Moreover, clinical findings such as high serum C-reactive protein levels and resistance to glucocorticoid treatment were crucial features of Castleman disease, contrasting sharply with IgG4-RD. Elevated serum concentrations of IgG4 and the finding of IgG4+PC infiltrates in systemic organs, including the kidneys, were common to both conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.
Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.
Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688–99.
Sato Y, Kojima M, Takata K, et al. Multicentric Castleman’s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J Clin Pathol. 2010;63:1084–9.
Sato Y, Kojima M, Takata K, et al. Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman’s disease. Mod Pathol. 2009;22:589–99.
Takeuchi M, Sato Y, Takata K, et al. Cutaneous multicentric Castleman’s disease mimicking IgG4-related disease. Pathol Res Pract. 2012;208:746–9.
Ogoshi T, Kido T, Yatera K, et al. Assessment of pathologically diagnosed patients with Castleman’s disease associated with diffuse parenchymal lung involvement using the diagnostic criteria for IgG4-related disease. Lung. 2013;191:575–83.
Fajgenbaum DC, van Rhee F, Nabel CS. HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy. Blood. 2014;123:2924–33.
Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354–9.
Suneja S, Chidambaram M, Herzenberg AM, et al. Kidney involvement in multicentric castleman disease. Am J Kidney Dis. 2009;53:550–4.
El Karoui K, Vuiblet V, Dion D, et al. Renal involvement in Castleman disease. Nephrol Dial Transplant. 2011;26:599–609.
Xu D, Lv J, Dong Y, et al. Renal involvement in a large cohort of Chinese patients with Castleman disease. Nephrol Dial Transplant. 2012;27 Suppl 3:iii119–25.
Ahmed B, Tschen JA, Cohen PR, et al. Cutaneous castleman’s disease responds to anti interleukin-6 treatment. Mol Cancer Ther. 2007;6:2386–90.
Luo JM, Li S, Huang H, et al. Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital. BMC Pulm Med. 2015;15:34.
Diebold J, Tulliez M, Bernadou A, et al. Angiofollicular and plasmacytic polyadenopathy: a pseudotumourous syndrome with dysimmunity. J Clin Pathol. 1980;33:1068–76.
Summerfield GP, Taylor W, Bellingham AJ, et al. Hyaline-vascular variant of angiofollicular lymph node hyperplasia with systemic manifestations and response to corticosteroids. J Clin Pathol. 1983;36:1005–11.
Sato T, Wakabayashi Y, Hirasawa A, et al. Multicentric Castleman’s disease accompanied with both lymphoid interstitial pneumonia and interstitial nephritis. Rinsho Ketsueki. 1994;35:1322–8.
Frøkjaer Thomsen O, Ladefoged J. Castleman’s disease with renal infiltration by polyclonal plasma cells. Clin Nephrol. 1998;49:328–30.
Uthup S, Balachandran K, Ammal VA, et al. Renal involvement in multicentric Castleman disease with glomeruloid hemangioma of skin and plasmacytoma. Am J Kidney Dis. 2006;2:e17–24.
Morita-Hoshi Y, Tohda S, Miura O, et al. An autopsy case of multicentric Castleman’s disease associated with interstitial nephritis and secondary AA amyloidosis. Int J Hematol. 2008;87:69–74.
Ashinuma H, Kasamatsu N, Kobayashi T, et al. A case of multicentric Castleman’s disease with metachronous pulmonary and nephric (renal) involvement. Nihon Kokyuki Gakkai Zasshi. 2008;46:634–9.
Nagai K, Usui J, Noguchi K, et al. A case of multicentric Castleman’s disease with membranoproliferative glomerulonephritis type 3-like lesion. Pathol Int. 2011;11:686–90.
Otani N, Morishita Y, Oh I, et al. Successful treatment of a mesangial proliferative glomerulonephritis with interstitial nephritis associated with Castleman’s disease by an anti-interleukin-6 receptor antibody (tocilizumab). Intern Med. 2012;51:1375–8.
Zoshima T, Yamada K, Hara S, et al. Multicentric Castleman disease with tubulointerstitial nephritis mimicking IgG4-related disease: Two case reports. Am J Surg Pathol. 2016;40:495–501.
Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343–52.
Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615–26.
Houghton DC, Troxell ML. An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis. Mod Pathol. 2011;24:1480–7.
Yamaguchi Y, Kanetsuna Y, Honda K, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43:536–49.
Yoshita K, Kawano M, Mizushima I, et al. Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis. Nephrol Dial Transplant. 2012;27:2755–61.
Saeki T, Kawano M. IgG4-related kidney disease. Kidney Int. 2014;85:251–7.
Sato Y, Yoshino T. IgG4-related lymphadenopathy. Int J Rheumatol. 2012;2012:572539.
Kawano M, Saeki T. IgG4-related kidney disease – an update. Curr Opin Nephrol Hypertens. 2015;24:193–201.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Japan
About this chapter
Cite this chapter
Zoshima, T., Kawano, M., Hara, S., Nagata, M. (2016). Differential Diagnosis (2): Castleman Disease. In: Saito, T., Stone, J., Nakashima, H., Saeki, T., Kawano, M. (eds) IgG4-Related Kidney Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-55687-9_23
Download citation
DOI: https://doi.org/10.1007/978-4-431-55687-9_23
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-55686-2
Online ISBN: 978-4-431-55687-9
eBook Packages: MedicineMedicine (R0)